ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676372 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676372; 2) Community: the network communities that were significantly associated with the response to NSC 676372; 3) Molecule: the relationships between components within communities and NSC 676372; 4) MDR: the compounds that were significantly associated with the NSC 676372.

NSC Compound Enrichment Correlation
NSC 137679 9H-Purine-6(1H)-one, 2-amino-9-.beta.-D-ribofuranosyl-6-seleno- 0.00863223795880985 0.28314488
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.00863223795880985 0.11323615
NSC 321237 Mercury, (4-aminophenyl)(6-thioguanosinato-N7,S6)- 0.00863223795880985 0.19012439
NSC 606985 Camptothecin Derivative 0.00863223795880985 0.082181537
NSC 614491 8-Cl-cAMP, sodium salt 0.00863223795880985 0.30287078
NSC 616348 Irinotecan hydrochloride 0.00863223795880985 0.092423595
NSC 617581 Null 0.00863223795880985 -0.026235669
NSC 626108 Null 0.00863223795880985 0.17396239
NSC 643001 3'O-phosphono-(Z)-combretastatin A-4, ammonium salt, hydrate [10:15:4] 0.00863223795880985 0.15655899
NSC 649890 Alvocidib hydrochloride, 0.00863223795880985 0.22077099
Total:134  Current:34    [First] [Prev] [Next] [Last]